STAT Plus: Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite darkening skies hovering over the Pharmalot campus. Our spirits remain sunny thanks to the amusing official mascot, who is running up and down the stairs at a dizzying pace, and a few cups of delicious stimulation. Our choice today is maple bourbon, for those tracking this sort of thing. All of which brings us to say that it is time to get cracking. So here are a few items of interest. We hope your day goes well and, of course, do stay safe. …
Hundreds of millions of cloth face masks shipped to U.S. agencies, nonprofit organizations, and private companies by the Trump administration appear to have been allocated in a haphazard fashion, raising questions about inequitable distribution in the effort to beat back the Covid-19 pandemic, STAT reports. Under the $675 million program, businesses and other entities were provided with supplies of the free, reusable masks that in some cases far exceeded their needs.
Continue to STAT Plus to read the full story…
